UConn Health is the branch of the University of Connecticut that oversees clinical care, advanced biomedical research, and academic education in medicine. The main branch is located in Farmington, Connecticut, in the US.

There are 224 beds in Connecticut Bleeding and Clotting Disorders Center.

During the past decade, Connecticut Bleeding and Clotting Disorders Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Connecticut Bleeding and Clotting Disorders Center" #1 collaborator was "Takeda" with 2 trials as a collaborator, "CSL Behring" with 1 trials as a collaborator and "Octapharma" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Connecticut Bleeding and Clotting Disorders Center" are "Haemophilia" (1 trials), "Haemophilia A Without Inhibitor" (1 trials), "Haemophilia B Without Inhibitor" (1 trials), "Hemophilia" (1 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "Connecticut Bleeding and Clotting Disorders Center" in a lesser frequency.

The vast majority of trials in "Connecticut Bleeding and Clotting Disorders Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Connecticut Bleeding and Clotting Disorders Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Connecticut Bleeding and Clotting Disorders Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Connecticut Bleeding and Clotting Disorders Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".